These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Insights into the pathogenesis and treatment of painful diabetic neuropathy. Greig M; Tesfaye S; Selvarajah D; Wilkinson ID Handb Clin Neurol; 2014; 126():559-78. PubMed ID: 25410244 [TBL] [Abstract][Full Text] [Related]
27. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Elafros MA; Andersen H; Bennett DL; Savelieff MG; Viswanathan V; Callaghan BC; Feldman EL Lancet Neurol; 2022 Oct; 21(10):922-936. PubMed ID: 36115364 [TBL] [Abstract][Full Text] [Related]
28. Peripheral neuropathy in persons with diabetes. Handevidt F Clin Excell Nurse Pract; 2001; 5(1):17-20. PubMed ID: 11154389 [TBL] [Abstract][Full Text] [Related]
29. Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies. Kaur M; Misra S; Swarnkar P; Patel P; Das Kurmi B; Das Gupta G; Singh A Biochem Pharmacol; 2023 Sep; 215():115723. PubMed ID: 37536473 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region. Ponirakis G; Elhadd T; Al Ozairi E; Brema I; Chinnaiyan S; Taghadom E; Al Kandari J; Al Wotayan R; Al Ozairi A; Aljohani N; AlMistehi W; Al Qahtani N; Khan S; Dabbous Z; Siddique MA; Petropoulos IN; Khan A; Almuhannadi H; Ashawesh KA; Dukhan KM; Mahfoud ZR; Zirie MA; Jayyousi A; Malik RA J Diabetes Investig; 2022 Sep; 13(9):1551-1559. PubMed ID: 35445568 [TBL] [Abstract][Full Text] [Related]
32. [Biomarkers of the development and progression of diabetic polyneuropathy]. Karakulova YV; Filimonova TA Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):70-75. PubMed ID: 32929927 [TBL] [Abstract][Full Text] [Related]
33. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Iqbal Z; Azmi S; Yadav R; Ferdousi M; Kumar M; Cuthbertson DJ; Lim J; Malik RA; Alam U Clin Ther; 2018 Jun; 40(6):828-849. PubMed ID: 29709457 [TBL] [Abstract][Full Text] [Related]
34. A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults. Abrams RMC; Pedowitz EJ; Simpson DM Expert Rev Neurother; 2021 Mar; 21(3):259-266. PubMed ID: 33428495 [TBL] [Abstract][Full Text] [Related]
35. L-Methylfolate in Diabetic Peripheral Neuropathy: A Narrative Review. Christofides EA; Valentine V Endocr Pract; 2023 Aug; 29(8):663-669. PubMed ID: 37088147 [TBL] [Abstract][Full Text] [Related]
36. ER stress in diabetic peripheral neuropathy: A new therapeutic target. O'Brien PD; Hinder LM; Sakowski SA; Feldman EL Antioxid Redox Signal; 2014 Aug; 21(4):621-33. PubMed ID: 24382087 [TBL] [Abstract][Full Text] [Related]
37. A Cross-Sectional Web Survey of Satisfaction with Treatment for Pain in Participants with Suspected Diabetic Peripheral Neuropathic Pain in Both Feet. Deguchi T; Takatsuna H; Yokoyama M; Shiosakai K; Inoue T; Seki H; Uetake Y Adv Ther; 2021 Aug; 38(8):4304-4320. PubMed ID: 34235631 [TBL] [Abstract][Full Text] [Related]
38. Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study. Rosales-Hernandez A; Cheung A; Podgorny P; Chan C; Toth C Lipids Health Dis; 2014 Feb; 13():32. PubMed ID: 24520839 [TBL] [Abstract][Full Text] [Related]
39. Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy. Carmichael J; Fadavi H; Ishibashi F; Shore AC; Tavakoli M Front Endocrinol (Lausanne); 2021; 12():671257. PubMed ID: 34122344 [TBL] [Abstract][Full Text] [Related]
40. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Zhu J; Hu Z; Luo Y; Liu Y; Luo W; Du X; Luo Z; Hu J; Peng S Front Endocrinol (Lausanne); 2023; 14():1265372. PubMed ID: 38264279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]